Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 3Phase 1 3Phase 4 2Phase 3 1Phase 1/2 1

Status

Completed 8Terminated 3Withdrawn 2Recruiting 2Unknown 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1202OTHER 899NIH 140NETWORK 21UNKNOWN 3FED 3OTHER_GOV 2

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Thoracic Neoplasms 1Neoplasms by Site 1Neoplasms 1Lung Neoplasms 1Lung Diseases 1Liver Neoplasms 1Condylomata Acuminata 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Bronchogenic 1

Interventions

Injections 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Terminated × FED × Clear all
NCT01574222 2018-01-18

VTNSCLC

VA Office of Research and Development

Phase 1 Terminated
1 enrolled
Thoracic

Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Thoracic Neoplasms

NCT02115919 2016-08-19

Safety Study of Multikine in the Treatment of Perianal Warts

United States Naval Medical Center, San Diego

Phase 1 Terminated
4 enrolled

Condylomata Acuminata

NCT00216437 2007-11-12

Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma

James A. Haley Veterans Administration Hospital

Phase 1 Terminated
30 enrolled
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡